Abstract
Depression, despite the availability of a wide range of biological, pharmacological and psychological therapies, remains a major health problem. The social and economic cost, together with the immense personal and family suffering caused by this recurrent illness have stimulated a number of comparative studies to identify effective treatments. Although progress has undoubtedly been made and hundreds of reports on controlled and uncontrolled clinical trials, and review articles and chapters have been written on this subject (Cole, 1964; Cole and Davis, 1975), information regarding efficacy and choice of antidepressant drug management is surprisingly scant.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ananth, J., and Ruskin, R., 1974, Treatment of intractable depression, Int. Pharmacopsychiatry 9:218–229.
Angst, J., 1966, Zur Atiologie and Nosologie endogener depressiver, Psychosen. Monogr. Neurol. Psychiatr. 112:1–118.
Angst, J., 1970, Clinical aspects of imipramine, in: Tofranil, Verlag Stamp Ai and Cie, AG, Berne.
Angst, J., Baastrup, P., Grof, P., Hippius, H., Poldinger, W., and Weis, P., 1973, The course of monopolar depression and bipolar psychoses, Psychiatr. Neurol. Neurochir. 76:489–500.
Akindele, M. O., Evans, J. I., and Oswald, I., 1970, Monoamine oxidase inhibitors, sleep and mood, Electroenceph. Clin. Neurophysiol. 29:47–56.
Arnold, S. J., and Ginsburg, A., 1974, Enuresis: Treatment with imipramine, J. Am. Med. Assoc. 228:289–290.
Asberg, M., 1974a, Individualization of treatment with tricyclic compounds, Med. Clin. North Am. 58:1083–1091.
Asberg, M., 1974b, Plasma nortriptyline levels-relationship to clinical effects, Clin. Pharmacol. Ther. 16:215–229.
Asberg, M., Cronholm, B., Sjoqvist, F., and Tuck, D., 1970, Correlation of subjective side effects with plasma concentrations of nortriptyline, Br. Med. J. 4:18–21.
Ascher, E., 1951/52, A criticism of the concept of neurotic depression, Am. J. Psychiatry 108:901–908.
Ayd, F. J., 1974, Single daily dose of antidepressants, J. Am. Med. Assoc. 230:263–264.
Ayuso Gutierrez, J. L., and Lopez-Ibor Alino, J. J., 1971, Tryptophan and an MAOI (Nialamide) in the treatment of depression. A double-blind study, Int. Pharmacopsychiatry 6:92–97.
Bethune, H. C., Burrell, R. H., Culpan, R. H., and Ogg, G. J., 1964, Vascular crisis associated with monoamine oxidase inhibitors, Am. J. Psychiatry 121:245–248.
Bornstein, P. E., Clayton, P. J., Halikas, J. A., Maurice, W. L., and Robins, E., 1973, The depression of widowhood after thirteen months, Br. J. Psychiatry 122:561–566.
Braithwaite, R. A., Goulding, R., Theano, G., Baily, J., and Coppen, H., 1972, Plasma concentration of amitriptyline and clinical response, Lancet 1:1297–1300.
Burks, J. S., Walker, J. E., Rumack, B. H., and Ott, T. E., 1974, Tricyclic antidepressant poisoning and reversal of coma, choreoathetosis, and myoclonus by physostigmine, J. Am. Med. Assoc. 230:1405–1407.
Burrows, G. D., Davies, B., and Scoggins, B. A., 1972, Plasma concentration of nortriptyline and clinical response in depressive illness, Lancet 2:619–623.
Burrows, G. D., Scoggins, B. A., Turecek, L. R., and Davies, G., 1974, Plasma nortriptyline and clinical response, Clin. Pharmacol. Ther. 16:639–644.
Busfield, B. L., Schneller, P., and Capra, D., 1962, Depressive symptom or side effect? A comparative study of symptoms during pretreatment and treatment periods of patients on three antidepressant medications, J. Nero. Ment. Dis. 134:339–345.
Cammer, L., 1973, Antidepressants as a prophylaxis against depression in the obsessive compulsive person, Psychosomatics 14:201–206.
Carney, M. W. P., Roth, M., and Garside, R. F., 1965, The diagnosis of depressive syndromes and the prediction of ECT response, Br. J. Psychiatry 111:659.
Cole, J. O., 1964, The therapeutic efficacy of antidepressant drugs: A review, J. Am. Med. Assoc. 190:448–455.
Cole, J. O., and Davis, J. M., 1975, in: Antidepressant Drugs (A. M. Freedman, H. I. Kaplan, and B. J. Sadock, eds.), pp. 1941–1956, Williams and Wilkins, Baltimore.
Coppen, A., Whybrow, P. C., Norguera, R., Maggs, R., and Prange, A. J., 1972, The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by 1-liothyronine, Arch. Gen. Psychiatry 26:234–241.
Cowl, L., Lipman, R. S., Derogatis, L. R., Smith, J. E., and Pattison, J. H., 1974, Drugs and group psychotherapy in neurotic depression, Am. J. Psychiatry 131:191–198.
Detre, T. P., and Jarecki, H. G., 1971, Modern Psychiatric Treatment, J. B. Lippincott, Philadelphia.
Detre, T. P., Himmelhoch, J., Swartzburg, M., Anderson, C. M., Byck, R., and Kupfer, D. J., 1972, Hypersomnia and manic-depressive disease, Am. J. Psychiatry 128:1303–1305.
Drotar, D., 1974, Concern over the categorization of depression in children, J. Pediatr. 85:290–291.
Dunleavy, D. L., and Oswald, I., 1973, Phenelzine, mood response, and sleep, Arch. Gen. Psychiatry 28:353–356.
Fawcett, J., 1975, Biochemical and neuropharmacological research, in: Depression and Human Existence (E. J. Anthony and T. Benedek, eds.), pp. 21–52, Little Brown and Company, Boston.
Feighner, J. P., King, L. J., Schuckit, M. A., Croughan, J., and Briscoe, W., 1972, Hormonal potentiation of imipramine and ECT in primary depression, Am. J. Psychiatry 128:1230–1238.
Friedman, A. S., 1975, Interaction of drug therapy with marital therapy in depressive patients, Arch. Gen. Psychiatry 32:619–637.
Gittelman-Klein, R., and Klein, D. R., 1972, School phobia: Diagnostic consideration in the light of imipramine effects in drugs, development, in: Cerebral Function (W. L. Smith, ed.), pp. 200–223, Charles C. Thomas, Springfield, Illinois.
Glassman, A. H., Kantor, S. J., and Shostak, M., 1975, Depression, delusions and drug response, Am. J. Psychiatry 132:716–719.
Goel, K. M., and Shanks, R. A., 1974, Amitriptyline and imipramine poisoning in children, Br. Med. J. 1:261–263.
Goldberg, H. L., Finnerty, R. J., Nathan, L., and Cole, J. O., 1974, Doxepin in a single bedtime dose in psychoneurotic outpatients, Arch. Gen. Psychiatry 31:513–517.
Gomersall, J. D., and Stuart, A., 1973, Amitriptyline in migraine prophylaxis, J. Neurol. Neurosurg. Psychiatry 36:684–690.
Greenberg, L. M., Yellin, A. M., Spring, C., and Metcalf, M., 1975, Clinical effects of imipramine and methylphenidate in hyperactive children, Int. J. Ment. Health 4:144–156.
Grof, P., Saxena, B., Cantor, R., Kaigle, L., Hetherington, D., and Haines, T., 1974, Doxepin versus amitriptyline in depression: A sequential double-blind study, Curr. Ther. Res. 16:470–476.
Guilleminault, C., Carskadon, M., Dement, W. C., 1974, On the treatment of rapid eye movement narcolepsy, Arch. Neurol. 30:90–93.
Guze, S. B., Woodruff, R. A., and Clayton, P. J., 1971, Secondary affective disorder: A study of 95 cases, Psychol. Med. 1:426–428.
Hamilton, M., and White, J. M., 1959, Clinical syndromes in depressive states, J. Ment. Sci. 105:985.
Haskell, D. S., Dimascio, A., and Prusoff, B., 1975, Rapidity of symptom reduction in depressions treated with amitriptyline, J. Neru. Ment. Dis. 160:24–33.
Hayes, T. A., Panitch, M. L., and Barker, E., 1975, Imipramine dosage in children: A comment on “imipramine and electrocardiographic abnormalities in hyperactive children,” Am. J. Psychiatry 132:546–547.
Herzog, A., and Detre, T., 1974, Postpartum psychoses, Dis. Nerv. Syst. 35:231–236.
Himmelhoch, J. M., Detre, T. P., Kupfer, D. J., Swartzburg, M., and Byck, R., 1972, Treatment of previously intractable depressions with tranylcypromine and lithium, J. Nero. Ment. Dis. 155:216–220.
Hippius, H., 1972, The current status of treatment for depression, in: Depressive Illness, Diagnosis, Assessment, Treatment (P. Keilholz, ed.), pp. 49–58, H. Huber, Bern.
Hollister, L. E., 1974, Doxepin hydrochloride, Ann. Intern. Med. 81:360–363.
Hollister, L. E., Overall, J. E., and Johnson, M. H., 1966, Amitriptyline alone and combined with perphenazine in newly admitted depressed patients, J. New. Ment. Dis. 142:460–469.
Jacobsson, L., Glitterstam, K., and Palm, U., 1974, Objective assessment of anticholinergic side effects of tricyclic antidepressants, Acta Psychiatr. Scand. Suppl. 255:47–53.
Johnstone, E. C., and Marsh, W., 1973, Acetylator status and response to phenelzine in depressed patients, Lancet 1:567–570.
Kay, D. W. K., Fahy, T., and Garside, R. F., 1970, A seven-month double-blind trial of amitriptyline and diazepam in ECT treated depressed patients, Br. J. Psychiatry 117:667.
Kay, D. W. K., Garside, R. F., and Fahy, T. J., 1973, A double-blind trial of phenelzine and amitriptyline in depressed out-patients. A possible differential effect of the drugs on symptoms, Br. J. Psychiatry 123:63–67.
Kiloh, L. G., and Garside, R. F., 1963, The independence of neurotic depression and endogenous depression, Br. J. Psychiatry 109:451.
Kiloh, L. G., Ball, J. R. B., and Garside, R. F., 1962, Prognostic factors in treatment of depressive states with imipramine, Br. Med. J. 1:1225–1227.
Klein, D. F., 1964, Delineation of two-drug responsive anxiety syndromes, Psychopharmacologa 5:397.
Klein, D. F., 1974, Endogenomorphic depression. A conceptual and terminological revision, Arch. Gen. Psychiatry 31:447–454.
Klein, D. F., and Davis, J. M., 1969, Diagnosis and Drug Treatment of Psychiatric Disorders, Williams and Wilkins, Baltimore.
Klerman, G. L., Dimascio, A., Weissman, M., Prusoff, B., and Paykel, E. S., 1974, Treatment of depression by drugs and psychotherapy, Am. J. Psychiatry 131:186–191.
Kotin, J., Post, R. M., and Goodwin, F. K., 1973, Drug treatment of depressed patients referred for hospitalization, Am. J. Psychiatry 130:1139–1141.
Kraeplin, E., 1921, Manic Depressive Insanity and Paranoia, E. S. Livingstone, Edinburgh.
Kragh-Sorensen, P., Hansen, C. E., and Asberg, M., 1973, Plasma levels of nortriptyline in the treatment of endogenous depression, Acta Psychiatr. Scand. 49:444–456.
Kragh-Sorensen, P., Hansen, C. E., Larsen, N. E., Naestoft, J., and Hvidberg, E. F., 1974, Long-term treatment of endogenous depression with nortriptyline with control of plasma levels, Psychol. Med. 4:174–180.
Kupeer, D. J., and Detre, T. P., 1971, Once more on the extraordinary side effects of drugs, Clin. Pharmacol. Ther. 12:575–582.
Kupfer, D. J., and Foster, F. G., 1975, The sleep of psychotic patients: Does it all look alike? in: Biology of the Major Psychoses: A Comparative Analysis (D. X. Freedman, ed.), pp. 143–159, Raven Press, New York.
Kupfer, D. J., Detre, T. P., and Himmelhoch, J., 1973, Classification of depression. A guide for the clinician. Symposium: Advances in the Treatment of Affective Disturbances, Rutgers University, New Brunswick, New Jersey.
Kupfer, D. J., Pickar, D., Himmelhoch, J. M., and Detre, T. P., 1975a, Are there two types of unipolar depression?, Arch. Gen. Psychiatry 32:886–891.
Kupfer, D. J., Foster, F. G., Detre, T. P., and Himmelhoch, J., 1975b, Sleep EEG and motor activity as indicators in affective states, Neuropsychobiology 1:296–303.
Leonhard, K., Koref, I., Schulz, H., 1962, Temperament in families with monopolar and bipolar phasic psychoses, Psychiatr. Neurol. (Basel) 143:416.
Levine, J., and Raskin, A., 1974, Predicting treatment responsiveness-resistiveness in a population of depressed patients, Pharmakopsychiatrie 7:217–222.
Lingjaerde, O., Edlund, A. H., Gormsen, C. A., Gottfries, C. G., Haugstad, A., Hermann, I. L., Hollnagel, P., Makimattila, A., Rasmussen, K. E., Remvig, J., and Robak, O. H., 1974, The effect of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. A double-blind, multicenter trial, Acta Psychiatr. Scand. 50:233–242.
Lopez-Ibor Alino, J. J., Ayuso Gutierrez, J. L., and Montejo Iglesias, M. L., 1973, Tryptophan and amitriptyline in the treatment of depression, Int. Pharmacopsychiatry 8:145–151.
Mapother, E., 1926, Discussion on manic-depressive psychosis, Br. Med. J. 2:872–879.
Martin, G. I., and Zaug, P. J., 1975, Electrocardiographic monitoring of enuretic children receiving therapeutic doses of imipramine, Am. J. Psychiatry 132:540–542.
Mcclure, D. J., Low, G. L., and Gent, M., 1973, Clomipramine HCI-a double-blind study of a new antidepressant drug, Can. Psychiatr. Assoc. J. 18:403–408.
Medical Letter, 1974a, Imipramine for enuresis, Med. Lett. 16:22–24.
Medical Letter, 1974b, Sunscreen, Med. Lett. 16:60.
Medical Letter, 1975a, Antidepressant drugs, Med. Lett. 17:1–3.
Medical Letter, 1975b, Adverse interactions of drugs, Med. Lett. 17:17.
Mendels, J., and Digiacomo, J., 1973, The treatment of depression with a single daily dose of imipramine pamoate, Am. J. Psychiatry 130:1022–1024.
Mindham, R. H. S., Howland, C., and Shepherd, M., 1973, An evaluation of continuation therapy with tricyclic antidepressants in depressive illness, Psychol. Med. 3:5–17.
Morris, J. B., and Beck, A. T., 1974, The efficacy of antidepressant drugs, Arch. Gen. Psychiatry 30:667–674.
O’Regan, J. B., 1974, Hypersomnia and MAOI antidepressants, Can. Med. Assoc. J. 111:213.
Ossofsky, H. J., 1974, Endogenous depression in infancy and childhood, Camp. Psychiatry 15:19–25.
Paykel, E. S., 1972, Depressive typologies and response to amitriptyline, Br. J. Psychiatry 120:147–156.
Paykel, E. S., Dimascio, A., Haskell, D., and Prusoff, B. A., 1975, Effects of maintenance amitriptyline and psychotherapy on symptoms of depression, Psychol. Med. 5:66–77.
Perris, C., 1966, A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses, Acta Psychiatr. Scand. 42 (Suppl. 194):1–188.
Perris, C., 1971, Personality patterns in patients with affective disorders, Acta Psychiatr. Scand. 47:43–50.
Petti, T. A., and Campbell, M., 1975, Imipramine and seizures, Am. J. Psychiatry 132:538–540.
Prange, A. J., 1975, Pharmacotherapy of depression, in: The Nature and Treatment of Depression (F. F. Flach and S. C. Draghi, eds.), pp. 255–269, John Wiley & Sons, New York.
Prange, A. J., Wilson, I. C., Knox, A., Mcclane, T. K., and Lipton, M. A., 1970, Enhancement of imipramine by thyroid stimulating hormone: Clinical and theoretical implications, Am. J. Psychiatry 127:191–199.
Prien, R. F., Klett, C. J., and Caffey, E. M., 1973, Lithium carbonate and imipramine in prevention of affective episodes, Arch. Gen. Psychiatry 29:420–425.
Quinn, P. O., and Rapoport, J. L., 1975, One-year follow-up of hyperactive boys treated with imipramine or methylphenidate, Am. J. Psychiatry 132:241–245.
Rapoport, J. L., Quinn, P. O., Bradbard, G., Riddle, K. D., and Brooks, E., 1974, Imipramine and methylphenidate treatments of hyperactive boys, Arch. Gen. Psychiatry 30:789–793.
Raskin, A., 1972, Adverse reactions to phenelzine: Results of a nine hospital depression study, J. Clin. Pharmacol. 12:22–25.
Raskin, A., 1974, A guide for drug use in depressive disorders, Am. J. Psychiatry 131:181–185.
Raskin, A., Schulterbrandt, J. G., Reatig, N., and Mckeon, J. J., 1970, Differential response to chlorpromazine, imipramine, and placebo, Arch. Gen. Psychiatry 23:164–173.
Ravaris, C. L., Nies, A., Robinson, D. S., Ives, J. O., Lamborn, K. R., and Korson, L., 1976, A multiple dose, controlled study of phenelzine in depression-anxiety states, Arch. Gen. Psychiatry 33:347–350.
Rickels, K., Hutchinson, J. C., Weise, C. C., Csanalosi, I., Chung, M. R., and Case, W., 1972, Doxepin and amitriptyline-perphenazine in mixed anxious-depressed neurotic outpatients: A collaborative study, Psychopharmacologia 23:305–318.
Rickels, K., Weise, C. C., Csanalosi, I., Chung, H. R., Feldman, H. S., Resenfeld, H., and Whalen, E. M., 1974, Clomipramine and amitriptyline in depressed outpatients. A controlled study, Psychopharmacologia 34:361–376.
Robins, E., and Guze, S. B., 1972, Classification of affective disorders: The primary-secondary, the endogenous-reactive, and the neurotic-psychotic concepts, in: Recent Advances in the Psychobiology of Depressive Illnesses (T. A. Williams, M. M. Katz, and J. A. Shield, eds.), U.S. Govt. Printing Office, Washington, D.C.
Robinson, D. S., Nies, A., Ravaris, C. L., and Lamborn, K. R., 1973, The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety states, Arch. Gen. Psychiatry 29:407–413.
Rosenthal, S., and Gudeman, J., 1967, The self-pitying constellation in depression, Br. J. Psychiatry 113:485–489.
Rosenthal, S. H., and Klerman, G. L., 1966, Content and consistency in the endogenous depressive pattern, Br. J. Psychiatry 112:471–484.
Roth, M., and Myers, D. H., 1969, Anxiety neuroses and phobic states: II. Diagnosis and management, Br. Med. J. 1:559–562.
Safer, D., Allen, R., and Bart, E., 1972, Depression of growth in hyperactive children on stimulant drugs, N. Engl. J. Med. 287:217–220.
Sargent, W., 1961, Drugs in the treatment of depression, Br. Med. J. 1:225–227.
Schuckit, M., Robins, E., and Feighner, J., 1971, Tricyclic antidepressants and monoamine oxidase inhibitors: Combination therapy in the treatment of depression, Arch. Gen. Psychiatry 24:509–514.
Schulterbrandt, J. G., Raskin, A., and Reatig, N., 1974, True and apparent side effects in a controlled trial of chlorpromazine and imipramine in depression, Psychopharmacologia 38:303–317.
Seager, C. P., and Bird, R. L., 1962, Imipramine with electrical treatment in depression: A controlled trial, J. Ment. Sci. 108:704–707.
Shaw, D. M., Johnson, A. L., and Macsweeney, D. A., 1972, Tricyclic antidepressants and tryptophan in unipolar affective disorder, Lancet 2:1245.
Snyder, B. D., Blonde, L., Mcwhirter, W. R., 1974, Reversal of amitriptyline intoxication by physostigmine, J. Am. Med. Assoc. 230:1433–1434.
Spiker, D. G., and Pugh, D. D., 1976, Combining tricyclic and monoamine oxidase inhibitor antidepressants, Arch. Gen. Psychiatry 33:828–830.
Spiker, D. G., Weiss, A. N., Chang, S. S., Ruwitch, J. F., and Biggs, J. T., 1975, Tricyclic antidepressant overdose: Clinical presentation and plasma levels, Clin. Pharmacol. Ther. 18:539–546.
Strauss, J., 1973, Diagnostic models and the nature of psychiatric disorder, Arch. Gen. Psychiatry 29:445–449.
Taub, A., 1975, Factors in the diagnosis and treatment of chronic pain, J. Autism Child. Schizoph. 5:1–12.
Teychenne, P. F., Calne, D. B., Lewis, P. J., and Findley, L. J., 1975, Interactions of levodopa with inhibitors of monoamine oxidase and L-aromatic amino acid decarboxyl-ase, Clin. Pharmacol Ther. 18:273–277.
Tyber, M. A., 1975, The relationship between hiatus hernia and tricyclic antidepressants: A report of five cases, Am. J. Psychiatry 132:652–653.
Waizer, J., Hoffman, S. P., Polizos, P., and Engelhardt, D. M., 1974, Outpatient treatment of hyperactive school children with imipramine, Am. J. Psychiatry 131:587–591.
Walker, R. D., Deture, F. A., Fennell, R. S., and Richard, G. A., 1974, Enuresis, diagnosis and management, J. Fla. Med. Assoc. 61:861–864.
Watts, C. A. H., 1957, The mild endogenous depression, Br. J. Med. 1:4–8.
Weinberg, W. A., Rutman, J., Sullivan, L., Penick, E. C., and Dietz, S. G., 1973, Depression in children referred to an educational diagnostic center: Diagnosis and treatment. Preliminary report, J. Pediatr. 83:1065–1072.
Weissman, M. M., Klerman, G. L., Paykel, E. S., Prusoff, B., and Hanson, B., 1974, Treatment effects on the social adjustment of depressed patients, Arch. Gen. Psychiatry 30:771–778.
West, E. D., and Dally, T. J., 1959, Effects of iproniazid in depressive syndromes, Br. Med. J. 1:1491–1494.
Wheatley, D., 1972, Potentiation of amitriptyline by thyroid hormone, Arch. Gen. Psychiatry 26:229–233.
Whybrow, P. C., Coppen, A., Prange, A. J., Noguera, R., and Bailey, J. E., 1972, Thyroid function and the response to 1-iothyronine in depression, Arch. Gen. Psychiatry 26:242–245.
Winokur, G., Clayton, P. J., and Reich, T., 1969, Manic-Depressive Illness, C. V. Mosby, St. Louis, Missouri.
Winsberg, B. G., Goldstein, S., Yepes, L. E., and Perel, J. M., 1975, Imipramine and electrocardiographic abnormalities in hyperactive children, Am. J. Psychiatry 132:542–545.
Woodruff, R. A., Goodwin, J. W., and Guze, S. B., 1974, Psychiatric Diagnosis, pp. 3–24, Oxford University Press, New York.
Wyatt, R. J., Fram, D. H., Buchbinder, R., and Snyder, F., 1971a, Treatment of intractable narcolepsy with a monoamine oxidase inhibitor, New Engl. J. Med. 285:987–991.
Wyatt, R. J., Fram, D., Kupfer, D. J., and Snyder, F., 1971b, Total prolonged drug-induced rapid eye movement sleep suppression in anxious-depressed patients, Arch. Gen. Psychiatry 24:145–155.
Zall, H., 1971, Lithium carbonate and isocarboxazid-an effective drug approach in severe depression, Am. J. Psychiatry 127:136–139.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Kupfer, D.J., Detre, T.P. (1987). Tricyclic and Monoamine-Oxidase-Inhibitor Antidepressants: Clinical Use. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds) Handbook of Psychopharmacology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4045-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4045-4_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4047-8
Online ISBN: 978-1-4613-4045-4
eBook Packages: Springer Book Archive